Plant glyco-biotechnology

Area of Science:

• Biochemistry
• Molecular Biology
• Plant Biotechnology

Background:

• Glycosylation is a crucial post-translational modification in eukaryotes.
• Early N-glycosylation steps are conserved in mammals and plants, but Golgi-based maturation differs significantly.
• Plants lack specific enzymes and nucleotide sugars, limiting their native glycan diversity.

Purpose of the Study:

• To explore the differences in glycosylation pathways between plants and mammals.
• To highlight the potential of plants for producing homogenous and custom N- and O-glycans.
• To underscore the application of plant-based glycosylation for improved biopharmaceuticals.

Main Methods:

• Comparative analysis of glycosylation pathways in plants and mammals.
• Identification of key enzymes and nucleotide sugars involved in glycan synthesis.
• Evaluation of plant systems for recombinant glycoprotein production.

Main Results:

• Plant Golgi N-glycan processing is less complex than in mammals.
• Mammalian O-glycosylation pathways are absent in plants, allowing for de novo pathway construction.
• Plants can produce homogenous N- and O-glycans, suitable for custom glycan engineering.

Conclusions:

• Plant glycosylation machinery is well-suited for producing homogenous N- and O-glycans.
• Plants are valuable platforms for generating recombinant glycoproteins with tailored glycan structures.
• Custom glycan engineering in plants can lead to biopharmaceuticals with enhanced therapeutic efficacy.